Get the Daily Brief

All action, no filler. BioBriefs delivers the industry’s 10 must-know updates, every morning.

Latest Biotech News

Oncology – HER2 neoadjuvant pill matches antibody standard

October 11, 2026

Pyrotinib-based neoadjuvant therapy using a pill regimen achieved pathological response rates comparable to the standard trastuzumab–pertuzumab combination in a multicenter phase II trial in...

Neuroinflammation – Nivolumab-linked hypophysitis mapping

October 11, 2026

A patient-level synthesis of 40 published cases shows nivolumab-induced hypophysitis primarily damages the pituitary’s cortisol-regulating axis, typically responds to corticosteroids, and rarely...

Cell therapy – Radiation strategy preserves CAR T effect in brain lymphoma

October 11, 2026

A rat study reports that spatially fractionated minibeam radiation preserved the efficacy of CD19-directed CAR T cells in a brain lymphoma model and extended survival compared with conventional...

Infection diagnostics & care – CT vs angiography for hemoptysis planning

October 11, 2026

A retrospective Chinese study of 81 patients with hemoptysis found CT angiography measures bronchial arteries only marginally larger than digital subtraction angiography (ID: 6c2c253e606f46d5)....

Endocrinology & aging – Consensus roadmap for palliative cancer care

October 11, 2026

A three-round European e-Delphi process produced 70 consensus statements defining how specialist palliative care should serve patients living with stable locally advanced or metastatic cancer (ID:...

Metformin & chemo toxicity – Lymphatic vessel protection in models

October 11, 2026

New preclinical research reports that metformin shields lymphatic vessels from mitochondrial damage caused by 5-fluorouracil and reduces lymphedema in mouse models (ID: e6d9e920130cc98f). The...

Clinical trials – Weekly vs every-three-week cisplatin acute toxicity

October 11, 2026

In the Phase II portion of the NRG-HN009 trial, weekly cisplatin did not significantly reduce acute toxicity compared with every-three-week dosing in patients with p16-negative locally advanced...

Immunotherapy safety – CAR T liver injury linked to cytokine release syndrome

October 11, 2026

A pharmacovigilance analysis of nearly five million adverse-event reports concludes that liver injury after CAR T-cell therapy is predominantly early and linked to cytokine release syndrome, with...

Ophthalmology innovation – Optogenetic therapy shows vision gains

October 11, 2026

An international trial led by University of Pittsburgh scientists reported that an optogenetic gene therapy combined with light-projecting goggles was safe and improved visual function in some...

Battery/biotech-adjacent manufacturing tech – Lithium surface standardization

October 11, 2026

Researchers developed a modular etching–brushing–soaking protocol to standardize lithium metal surfaces, improving reproducibility and full-cell battery performance (ID: 5db8f51035f8b91d). While...

Clinical trial and consensus updates in Parkinson’s disease

October 11, 2026

Dual-release levodopa formulation IPX203 has received expert-consensus endorsement for use in European patients with Parkinson’s motor fluctuations, targeting improved timing of dopamine...

Imaging and diagnostics: breast, TB, and cancer risk stratification

October 11, 2026

A large surveillance study reports that automated breast ultrasound matches handheld screening accuracy in women with dense breasts while reducing false alarms, potentially changing workflow...

HIV and infectious disease: immune engineering, long-term burden, and evolving surveillance

October 11, 2026

Cryo-EM work has clarified how HIV-1’s Vpr protein hijacks the human CRL4(VprBP) E3 ligase to degrade diverse host targets—an upstream mechanistic map that can guide antiviral strategy...

Immuno-oncology biology and tumor microenvironment mechanisms

October 11, 2026

A study in advanced science connects tumor-secreted LRG1 to neutrophil mitochondrial dysfunction and NET release, describing a pathway that destabilizes tumor vessels and undermines...

CAR T and radiation: platform-level evidence for combination strategies

October 11, 2026

A rat study reports that grid-shaped radiation boosts CD19-directed CAR T cell efficacy in brain lymphoma, preserving survival compared with conventional radiotherapy approaches. Separately, a...

Rare and high-burden diseases: maternal-newborn care and congenital conditions

October 11, 2026

A major review and meta-analysis concludes that fetal lung drainage (pleuro-amniotic shunting) saves roughly two-thirds of babies with isolated pleural effusion and can reverse hydrops in most...

Cancer treatment evidence: dosing strategy and predictive imaging markers

October 11, 2026

A Phase II component of the NRG-HN009 trial finds weekly cisplatin does not significantly reduce acute toxicity versus every-three-week dosing in p16-negative locally advanced head and neck...

Diabetes and metabolic risk: drug safety signals and early warning biomarkers

October 11, 2026

A meta-analysis links long-term metformin use with peripheral neuropathy risk, attributing part of the association to vitamin B12 depletion affecting about a third of treated patients. A nested...

Neurology and immunology crossovers: Alzheimer’s detection and post-COVID symptom stratification

October 11, 2026

An AI system using routine MRI scans reports the ability to detect subjective cognitive decline—the earliest preclinical stage of Alzheimer’s—though the work frames performance around clinically...

Biotech platform and translational science: AI and open-source tools for clinical research workflows

October 11, 2026

An open-source R workflow called SLR Suite aims to make systematic literature reviews reproducible by bundling bibliometrics, TCCM coding, and version-controlled controls into a single...